Rocket Lab (RKLB) Q2 2026 earnings review
Accelerating Scale Amid a Landmark Transformation
Rocket Lab posted a massive Q2, delivering record revenue of $234 million (+62% YoY) and expanding its backlog to an unprecedented $2.36 billion. But the financial numbers are secondary to the strategic narrative: the blockbuster acquisition of Iridium Communications, alongside completed deals for Mynaric and Motiv, officially shifts the company from a launch provider to a vertically integrated, tier-1 space prime. While Q3 guidance projects another revenue record, profitability is reversing course with Adjusted EBITDA losses expected to widen as the company absorbs its new acquisitions and heavily funds the Neutron rocket's development.
🐂 Bull Case
Backlog surged 137% YoY to $2.36 billion. Post-quarter signings added another $1 billion, providing immense revenue visibility and validating their shift toward large-scale Space Systems contracts.
The Iridium acquisition, combined with the $397M SB-AMTI award and $160M geostationary domain awareness contract, proves Rocket Lab is now successfully outbidding legacy primes for tier-1 national security infrastructure.
🐻 Bear Case
After narrowing its Adjusted EBITDA loss to $8.8M in Q2, Q3 guidance signals a reversing trend. Widening losses ($17-$23M) and gross margin compression highlight the high near-term costs of integrating aggressive M&A.
Integrating massive acquisitions (Iridium, Mynaric, Motiv) while simultaneously rushing to deliver the new medium-lift Neutron rocket to the pad by Q4 2026 creates an incredibly complex operational tightrope.
⚖️ Verdict: 🟢
Bullish. The near-term margin hit is a necessary toll for what Rocket Lab is achieving. They are aggressively rolling up the space supply chain to build a fully vertically-integrated telecom and launch monopoly. If they successfully digest Iridium and launch Neutron, the TAM expansion is staggering.
Key Themes
The Iridium Acquisition: A Monumental Shift
The landmark agreement to acquire Iridium Communications radically transforms the company's profile. Rocket Lab is no longer just selling rockets and satellite parts; it is acquiring a massive, cash-generating global satellite constellation. This completes the CEO's vision of becoming a self-launching, end-to-end space applications powerhouse. This instantly provides recurring telecom revenue and internalizes a major customer payload.
National Security Wins Validate Prime Strategy
The strategy to vertically integrate and bid as a prime is paying off in hard dollars. The company was awarded a $397 million contract to deliver Flatellite spacecraft for the Space Force's SB-AMTI program, plus $160 million to build geostationary satellites. Being one of only two vendors for SB-AMTI validates that the Department of Defense views Rocket Lab on par with legacy aerospace giants.
Near-Term Margin Deceleration
Despite achieving a record 41.5% Non-GAAP gross margin in Q2, Q3 guidance forecasts a severe deceleration to 35-37%. GAAP margins are expected to drop to 29-31%. This mix-shift margin compression, combined with expected Adjusted EBITDA losses doubling sequentially to ~$20M, underscores the heavy friction costs of integrating newly acquired units like Mynaric and standing up massive government satellite programs.
Neutron Development Reaches Critical Assembly Phase
The medium-lift Neutron rocket is making tangible progress toward its Q4 2026 pad delivery target. Production of the Stage 1 tank is actively aligned with this schedule. While the schedule has slipped in past quarters, moving from component testing to first-flight hardware assembly is a crucial de-risking milestone that unlocks future commercial mega-constellation deployments.
Other KPIs
Accelerating aggressively. Backlog grew 137% YoY, heavily weighted toward Space Systems. Factoring in the $1 billion in post-Q2 signings, Rocket Lab essentially has roughly three full years of forward revenue secured. This derisks the top line significantly.
Total liquidity surged from $828 million at the end of 2025. This massive war chest, heavily bolstered by previous ATM offerings and cash flows, provides the necessary dry powder to finance the Iridium acquisition and cover elevated CapEx for the Neutron build.
Product revenue (space systems/components) exploded by 95% YoY, completely eclipsing service revenue (launch), which grew a stable 2%. Rocket Lab is fundamentally a spacecraft manufacturing company now, with launch serving as a highly visible, strategic enabler.
Guidance
Accelerating. The midpoint of $257.5M implies an 8.6% sequential increase and massive YoY growth. It proves that production throughput is successfully keeping up with surging backlog demands.
Reversing. After narrowing the loss to just $8.8M in Q2, management expects losses to deepen to ~$20M in Q3. This confirms that bringing Mynaric up to standard and shifting mix toward lower-margin, high-volume government programs will suppress near-term profitability.
Decelerating. A stark drop from Q2's 41.5%. Investors should watch this closely; management is sacrificing short-term margin percentage for absolute dollar scale and strategic market share.
Key Questions
Iridium Financial Mechanics
How will the Iridium acquisition be financed, and how drastically will this alter the company's timeline to achieving positive free cash flow?
Gross Margin Floor
With Q3 Non-GAAP gross margin guided down to 36%, is this the expected floor as Mynaric integrates, or could margins compress further as the $397M SB-AMTI and other large Space Systems programs begin recognizing heavier revenue?
GHOST and Neutron Economics
How does the introduction of the GHOST deployable launch system impact the capital expenditure runway for Neutron, and does it cannibalize existing Launch Complex utilization?